General Neurology

Latest

Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions

Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions

In multivariable models, associations were observed between cardiovascular risk factors and cerebrovascular morphology, as well as white matter hyperintensity count.

Hospitalization Tied to Brain Abnormalities in Older Adults

Hospitalization Tied to Brain Abnormalities in Older Adults

Hospitalization is associated with lower white matter integrity among older adults.

FDA Issues Safety Communication Regarding Pen Needle Use

FDA Issues Safety Communication Regarding Pen Needle Use

Standard pen needles have an outer cover and removable inner needle cover, while safety pen needles have an outer cover and a fixed inner needle shield that is not removed before an injection.

New AAN Guidelines for the Management of Disorders of Consciousness

New AAN Guidelines for the Management of Disorders of Consciousness

The new guidelines place a substantial emphasis on the importance of introducing high-quality rehabilitation early in these patients.

Glial Cell Therapy Gets FDA's Orphan Drug Designation for Transverse Myelitis

Glial Cell Therapy Gets FDA's Orphan Drug Designation for Transverse Myelitis

The Company has obtained Investigational New Drug clearance for Phase 1/2a trials of Q-Cells in both TM and amyotrophic lateral sclerosis.

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve Diagnoses

Every nine minutes, a patient in a U.S. hospital dies because a diagnosis was wrong or delayed -- resulting in 80,000 deaths a year. .

Positive Results for Soliris in Neuromyelitis Optica Spectrum Disorder Trial

Positive Results for Soliris in Neuromyelitis Optica Spectrum Disorder Trial

In the PREVENT study, the safety and efficacy of Soliris was compared to placebo in patients with AQP4 auto antibody-positive NMOSD (N=143).

Hospitals Charge 479 Percent of Cost of Drugs on Average

Hospitals Charge 479 Percent of Cost of Drugs on Average

On average, hospitals mark up drugs by 479 percent of their cost, according to a report from The Moran Company, commissioned by the PhRMA.

Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored

Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored

A significant risk factor for autoimmune encephalitis was antibody detection within a 3-week period of herpes simplex encephalitis.

Drug Prices Increase More Than Expected After Shortages

Drug Prices Increase More Than Expected After Shortages

Prices for drugs under shortage increase more than twice as quickly as expected in the absence of a shortage.

Sign Up for Free e-newsletters



CME Focus